Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approaches

被引:24
作者
McMullin, Tami S.
Hanneman, William H.
Cranmer, Brian K.
Tessari, John D.
Andersen, Melvin E.
机构
[1] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA
[2] CIIT Ctr Hlth Res, Ctr Hlth Res, Res Triangle Pk, NC 27709 USA
关键词
PBPK modeling; atrazine; DACT;
D O I
10.1016/j.tox.2007.05.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Atrazine (ATRA) is metabolized by cytochrome P450s to the chlorinated metabolites, 2-chloro-4-ethylamino-6-amino-1,3,5triazine(gTHYL),2-chloro-4-amino-6-is,opropylamino-1, 3,5-triazine (ISO), and diaminochlorotriazine (DACT). Here,we develop a set of physiologically based pharmacokinetic (PBPK) models that describe the influence of oral absorption and oxidative metabolism on the blood time course curves of individual chlorotriazines (Cl-TRIs) in rat after oral dosing of ATRA. These models first incorporated in vitro metabolic parameters to describe time course plasma concentrations of DACT, ETHYL, and ISO after dosing with each compound. Parameters from each individual model were linked together into a final composite model in order to describe, the time course of all 4 CI-TRIs after ATRA dosing. Oral administration of ISO, ETHYL and ATRA produced double peaks of the compounds in plasma time courses that were described by multiple absorption phases from gut. An adequate description of the uptake and bioavailability of absorbed ATRA also required inclusion of additional oxidative metabolic clearance of ATRA to the mono-dealkylated metabolites occurring in GI a tract compartment. These complex processes regulating tissue dosimetry of atrazine and its chlorinated metabolites likely reflect limited compound solubility in the gut from dosing with an emulsion, and sequential absorption and metabolism along the GI tract at these high oral doses. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 33 条
[11]   INFLUENCE OF FIRST-PASS EFFECT ON AVAILABILITY OF DRUGS ON ORAL ADMINISTRATION [J].
GIBALDI, M ;
BOYES, RN ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1338-&
[12]   In vitro metabolism of chlorotriazines:: Characterization of simazine, atrazine, and propazine metabolism using liver microsomes from rats treated with various cytochrome P450 inducers [J].
Hanioka, N ;
Jinno, H ;
Tanaka-Kagawa, T ;
Nishimura, T ;
Ando, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 156 (03) :195-205
[13]   In vitro metabolism of simazine, atrazine and propazine by hepatic cytochrome P450 enzymes of rat, mouse and guinea pig, and oestrogenic activity of chlorotriazines and their main metabolites [J].
Hanioka, N ;
Jinno, H ;
Tanaka-Kagawa, T ;
Nishimura, T ;
Ando, M .
XENOBIOTICA, 1999, 29 (12) :1213-1226
[14]  
Iwao Takahiro, 2004, Drug Metab Pharmacokinet, V19, P430, DOI 10.2133/dmpk.19.430
[15]   The small intestine as a xenobiotic-metabolizing organ [J].
Kaminsky, LS ;
Zhang, QY .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (12) :1520-1525
[16]   A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat [J].
Lilly, PD ;
Andersen, ME ;
Ross, TM ;
Pegram, RA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 150 (02) :205-217
[17]   Estimating constants for metabolism of atrazine in freshly isolated rat hepatocytes by kinetic modeling [J].
McMullin, Tami S. ;
Andersen, Melvin E. ;
Tessari, John D. ;
Cranmer, Brian ;
Hanneman, William H. .
TOXICOLOGY IN VITRO, 2007, 21 (03) :492-501
[18]   Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action [J].
McMullin, TS ;
Andersen, ME ;
Nagahara, A ;
Lund, TD ;
Pak, T ;
Handa, RJ ;
Hanneman, WH .
TOXICOLOGICAL SCIENCES, 2004, 79 (02) :278-286
[19]   Pharmacokinetic modeling of disposition and time-course studies with [14C]atrazine [J].
McMullin, TS ;
Brzezicki, JM ;
Cranmer, BK ;
Tessari, JD ;
Andersen, ME .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2003, 66 (10) :941-964
[20]  
PANG KS, 1986, DRUG METAB DISPOS, V14, P102